Relapse after non‐metastatic rhabdomyosarcoma: The impact of routine surveillance imaging on early detection and post‐relapse survival

Patients with rhabdomyosarcoma (RMS) whose disease relapses have little chance of being cured, so front‐line treatments are usually followed up with surveillance imaging in an effort to detect any recurrences as early as possible, and thereby improve post‐relapse outcomes. The real benefit of such routine surveillance imaging in RMS remains to be demonstrated, however. This retrospective, single‐center study examines how well surveillance imaging identifies recurrent tumors and its impact on post‐relapse survival.